Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.34 EUR | -0.87% | -1.31% | -14.14% |
Apr. 05 | Biotechnology Assets, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Biotechnology Assets, S.A. Auditor Raises 'Going Concern' Doubt | CI |
Sales 2022 | 2.96M 3.21M | Sales 2023 | 3.91M 4.25M | Capitalization | 22.85M 24.83M |
---|---|---|---|---|---|
Net income 2022 | -1M -1.09M | Net income 2023 | 1M 1.09M | EV / Sales 2022 | 6.72 x |
Net Debt 2022 | 7.45M 8.09M | Net Debt 2023 | 3.72M 4.04M | EV / Sales 2023 | 6.8 x |
P/E ratio 2022 |
-6.41
x | P/E ratio 2023 |
14.5
x | Employees | 37 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 51.46% |
1 day | -0.87% | ||
1 week | -1.31% | ||
Current month | +1.19% | ||
1 month | -2.86% | ||
3 months | -12.14% | ||
6 months | -17.68% | ||
Current year | -14.14% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 60 | 19-10-31 | |
Javier Uría
COO | Chief Operating Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 06-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | - | - | |
Director/Board Member | - | - | |
John Dixon
BRD | Director/Board Member | 68 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 0.34 | -0.87% | 20,006 |
24-05-16 | 0.343 | -1.72% | 37,034 |
24-05-15 | 0.349 | -0.29% | 175,159 |
24-05-14 | 0.35 | +0.29% | 269,115 |
24-05-13 | 0.349 | +1.31% | 266,378 |
Delayed Quote BME, May 17, 2024 at 11:35 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-14.14% | 21.34M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- BST Stock